Kidney Cancer from Detection to Treatment
What Is Kidney Cancer?
Kidney cancer also called renal cancer begins in the kidneys - two bean-shaped organs that filter waste from the blood and make urine.
The most common type is Renal Cell Carcinoma.
Most kidney cancers are found accidentally during scans for other problems.
Kidney cancer also called renal cancer begins in the kidneys - two bean-shaped organs that filter waste from the blood and make urine.
The most common type is Renal Cell Carcinoma.
Most kidney cancers are found accidentally during scans for other problems.
1. Initial Detection / Screening
Symptoms:
Kidney cancer often causes no symptoms early on and is usually found incidentally during imaging for other conditions.
When symptoms appear, they may include:
Blood in urine | hematuria
Persistent flank or back pain
Lump or mass in the side or lower back
Unexplained weight loss or fatigue
Fever not caused by infection
High blood pressure or anemia
Incidental Detection:
Often discovered accidentally on ultrasound or CT scan done for other reasons.
Symptoms:
Kidney cancer often causes no symptoms early on and is usually found incidentally during imaging for other conditions.
When symptoms appear, they may include:
Blood in urine | hematuria
Persistent flank or back pain
Lump or mass in the side or lower back
Unexplained weight loss or fatigue
Fever not caused by infection
High blood pressure or anemia
Incidental Detection:
Often discovered accidentally on ultrasound or CT scan done for other reasons.
2. Diagnostic Testing
Ultrasound
First-line, non-invasive test.
Differentiates solid vs cystic mass.
CT Scan
Gold standard for diagnosis and staging.
Determines tumor size, location, and spread.
MRI
Used when CT contrast is contraindicated.
Helpful for assessing venous involvement.
Chest CT/X-ray
To check for lung metastasis.
Bone scan or PET-CT
Done if bone pain or advanced disease is suspected.
Ultrasound
First-line, non-invasive test.
Differentiates solid vs cystic mass.
CT Scan
Gold standard for diagnosis and staging.
Determines tumor size, location, and spread.
MRI
Used when CT contrast is contraindicated.
Helpful for assessing venous involvement.
Chest CT/X-ray
To check for lung metastasis.
Bone scan or PET-CT
Done if bone pain or advanced disease is suspected.
3. Confirmatory Tests
Urine Tests
Detects microscopic hematuria.
Rules out infection or other causes.
Blood Tests
Kidney function | creatinine, urea.
Liver enzymes | for possible metastasis.
CBC | for anemia or polycythemia.
Calcium levels | can be elevated in advanced cases.
Biopsy
Percutaneous needle biopsy is done when diagnosis is uncertain or before targeted therapy in advanced disease.
Sometimes skipped if imaging clearly shows typical renal cell carcinoma.
Urine Tests
Detects microscopic hematuria.
Rules out infection or other causes.
Blood Tests
Kidney function | creatinine, urea.
Liver enzymes | for possible metastasis.
CBC | for anemia or polycythemia.
Calcium levels | can be elevated in advanced cases.
Biopsy
Percutaneous needle biopsy is done when diagnosis is uncertain or before targeted therapy in advanced disease.
Sometimes skipped if imaging clearly shows typical renal cell carcinoma.
4. Staging
TNM System
T = Tumor size and extent within or beyond kidney.
N = Lymph node involvement.
M = Distant metastasis (lungs, bones, liver, brain).
Stages
Stage I - Tumor ≤7 cm, confined to kidney.
Stage II - Tumor >7 cm, still confined to kidney.
Stage III - Spread to nearby lymph nodes or major veins.
Stage IV - Distant metastases or invasion into adjacent organs.
TNM System
T = Tumor size and extent within or beyond kidney.
N = Lymph node involvement.
M = Distant metastasis (lungs, bones, liver, brain).
Stages
Stage I - Tumor ≤7 cm, confined to kidney.
Stage II - Tumor >7 cm, still confined to kidney.
Stage III - Spread to nearby lymph nodes or major veins.
Stage IV - Distant metastases or invasion into adjacent organs.
5. Treatment Options
Stage I–II - Surgery
Partial nephrectomy
Radical nephrectomy
Laparoscopic or robotic techniques often used.
Stage III
Radical nephrectomy + removal of affected lymph nodes or venous tumor thrombus.
Adjuvant targeted therapy may be considered (to reduce recurrence risk).
Stage IV
Targeted therapies:
VEGF inhibitors
mTOR inhibitors
Immunotherapy:
PD-1 inhibitors.
Combination of immunotherapy + targeted therapy often used first-line.
Cytoreductive nephrectomy
may be considered if overall health allows and metastases are limited.
Palliative radiation therapy
for pain or bone metastases.
Stage I–II - Surgery
Partial nephrectomy
Radical nephrectomy
Laparoscopic or robotic techniques often used.
Stage III
Radical nephrectomy + removal of affected lymph nodes or venous tumor thrombus.
Adjuvant targeted therapy may be considered (to reduce recurrence risk).
Stage IV
Targeted therapies:
VEGF inhibitors
mTOR inhibitors
Immunotherapy:
PD-1 inhibitors.
Combination of immunotherapy + targeted therapy often used first-line.
Cytoreductive nephrectomy
may be considered if overall health allows and metastases are limited.
Palliative radiation therapy
for pain or bone metastases.
6. Follow-Up and Monitoring
Schedule
Every 3-6 months for the first 3 years.
Then annually for 5 years.
Tests include:
Physical exam and labs | renal function.
CT/MRI scans of chest/abdomen/pelvis.
Monitoring for recurrence or metastasis.
Lifestyle support:
Avoid smoking and maintain healthy blood pressure.
Stay hydrated and eat kidney-friendly diet.
Schedule
Every 3-6 months for the first 3 years.
Then annually for 5 years.
Tests include:
Physical exam and labs | renal function.
CT/MRI scans of chest/abdomen/pelvis.
Monitoring for recurrence or metastasis.
Lifestyle support:
Avoid smoking and maintain healthy blood pressure.
Stay hydrated and eat kidney-friendly diet.
Read More
➛ Step by Step Overview
➛ Patient's Appeal
➛ Patients’ Stories
➛ Transparency Page
➛ Volunteer / Partner Page